相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
Robert Montal et al.
BRITISH JOURNAL OF CANCER (2019)
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Peter R. Galle et al.
LIVER INTERNATIONAL (2019)
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma
Yu-Yun Shao et al.
LIVER INTERNATIONAL (2019)
755PAlpha-fetoprotein (AFP) response in patients with unresectable hepatocellular carcinoma (HCC) in the phase III RESORCE trial
J Bruix et al.
ANNALS OF ONCOLOGY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study
Ian Chau et al.
BRITISH JOURNAL OF CANCER (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
148OAssessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)
T Yau et al.
ANNALS OF ONCOLOGY (2018)
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
Andrea Notarpaolo et al.
JOURNAL OF HEPATOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization
Chao He et al.
ONCOTARGET (2017)
VEGF overexpression predicts poor survival in hepatocellular carcinoma
Sae Byeol Choi et al.
OPEN MEDICINE (2017)
Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America
Federico Pinero et al.
LIVER INTERNATIONAL (2016)
Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan
Masatoshi Kudo et al.
LIVER CANCER (2016)
Relevance of Pre-Transplant α-fetoprotein Dynamics in Liver Transplantation for Hepatocellular Cancer
Michal Grat et al.
ANNALS OF TRANSPLANTATION (2016)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
Christian Toso et al.
HEPATOLOGY (2015)
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2015)
Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis
Hiroki Nishikawa et al.
JOURNAL OF CANCER (2015)
Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
Yong Kang Lee et al.
BMC CANCER (2013)
Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
Takahide Nakazawa et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Targeted inhibition of VEGF receptor 2: an update on ramucirumab
Jeffrey Melson Clarke et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization
Yan Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma
Young Eun Chon et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C-Related Hepatocellular Carcinoma
Gia L. Tyson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status
Yun-feng Shan et al.
MEDICAL ONCOLOGY (2011)
Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients With Advanced Hepatocellular Carcinoma
Yu-Yun Shao et al.
CANCER (2010)
Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy
Kentaroh Yamamoto et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis
S. J. Schoenleber et al.
BRITISH JOURNAL OF CANCER (2009)
New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy
Stephen L. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
Puneeta Tandon et al.
LIVER INTERNATIONAL (2009)
Serum alpha-Fetoprotein Response as a Surrogate for Clinical Outcome in Patients Receiving Systemic Therapy for Advanced Hepatocellular Carcinoma
Sadhna R. Vora et al.
ONCOLOGIST (2009)
EpCAM and α-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma
Taro Yamashita et al.
CANCER RESEARCH (2008)
Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome
K Shetty et al.
LIVER TRANSPLANTATION (2004)
Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
H Imamura et al.
JOURNAL OF HEPATOLOGY (2003)
Clinical characteristics and prognosis of hepatocellular carcinoma - Analaysis based on serum alpha-fetoprotein levels
P Tangkijvanich et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2000)
分享论文
